Dow Down0.22% Nasdaq Up0.14%

Galena Biopharma, Inc. (GALE)

-NasdaqCM
2.15 Down 0.05(2.27%) Aug 22, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 2,487   -   -  
Cost of Revenue520   -   -  
Gross Profit 1,967   -   -  
Operating Expenses
Research Development21,076  14,614  3,851  
Selling General and Administrative14,600  6,585  8,635  
Non Recurring -   -   -  
Others131   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (33,840) (21,199) (12,486)
Income from Continuing Operations
Total Other Income/Expenses Net(40,979)(13,145)9,086  
Earnings Before Interest And Taxes(75,626)(34,377)(3,407)
Interest Expense -   -   -  
Income Before Tax(75,626)(34,377)(3,407)
Income Tax Expense1,052  (1,052) -  
Minority Interest -   -   -  
Net Income From Continuing Ops(76,678)(33,325)(3,407)
Non-recurring Events
Discontinued Operations -  (1,644)(8,078)
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (76,678) (34,969) (11,485)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (76,678) (34,969) (11,485)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.